Add this topic to your myFT Digest for news straight to your inbox
Better awareness and access are needed to rebuild measles vaccination rates
Forerunners of pharma company tested vaccines at notorious institutions for decades
Mounjaro has achieved 22.5 per cent loss of body weight in trials
Chair of 100 Days Mission warns of huge economic cost if world cannot act swiftly to tackle pathogens
Swedish trial finds ‘high accuracy’ in identifying protein associated with toxic build-up in the brain
Shots will be given to children in Cameroon as part of rollout of up to 30mn jabs across continent
Research boosts efforts to diagnose and devise treatments for debilitating condition
Scientists are eavesdropping on animal conversations. Will generative AI enable us to talk back?
The global health community — together with pharmaceutical companies — must prove they take maternal rights seriously
‘Molecular factories’ boost field of synthetic biology, raising hopes of developing drugs and other products
Expanded genetic profiling could lead to breakthroughs in diagnosis and therapy for common tumours, landmark global study finds
H5N1 cases in South Georgia increase concerns about virus’s ability to adapt and infect mammals and humans more easily
Study harnesses millennia-old human DNA to plot ‘genetic divide’ on origin and spread of health risks
Medical experts call for curbs on agricultural fungicides
Oxford university spinout working on polygenic risk scores to help predict disease
Winter surge in people catching flu, Covid-19 or RSV risks overwhelming hospitals
A trial of $3 payments for getting a Covid jab in rural Ghana offers a game-changing way to meet public health goals
Potential remedy targets leading antibiotic-resistant pathogen that causes life-threatening infections in patients
Millions of Paxlovid pills have gone unused as tight controls restrict access
Focused adoption will follow this year’s fun experimentation
Americans’ interest in vaccinations has flagged despite efforts to boost uptake of latest jab
Debates about crucial topics such as AI and net zero currently exclude large swaths of the population
Research into ‘colonisation resistance’ boosts efforts to harness microbes to improve general health
Belfast-based CV6 Therapeutics announced MHRA approval for trials of novel therapy pill
Anglo-Swedish pharma group agrees to buy Seattle-based biotech Icosavax
International Edition